Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application

Polyclonal rabbit antithymocyte globulin (thymoglobulin): immunomodulatory effects and new aspects of its clinical application

Antithymocyte immunoglobulins remain to be one of the most effective immunosuppressants used in transplantology and in the treatment of autoimmune diseases. The unique features of the mechanisms of individual antithymocyte globulin preparations should be borne in mind. Due to its polyclonal nature,...

Full description

Bibliographic Details
Main Authors:	A D Kulagin, I A Lisukov, I A Miloserdov, B V Afanasyev
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2010-07-01
Series:	Терапевтический архив
Subjects:	polyclonal rabbit antithymocyte globulin thymoglobulin mechanisms of action immunomodulation immunosuppression solid organ transplantation hemopoietic cell transplantation aplastic anemia
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/30645

Similar Items

Role of antithymocyte globulin in reducing the incidence of complications after allogeneic hemopoietic cell transplantation
by: Yu R Zalyalov, et al.
Published: (2010-08-01)

Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin
by: de-Medeiros C.R., et al.
Published: (2000-01-01)

Acquired severe aplastic anemia treated with antithymocyte globulin and cyclosporine: An experience of regional cancer center, Western India
by: Ankit B Patel, et al.
Published: (2015-01-01)

Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium
by: Isa F. Ashoor, et al.
Published: (2021-04-01)

The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia
by: A A Ganapiyev, et al.
Published: (2010-07-01)

Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report
by: Yohan Park, et al.
Published: (2020-07-01)

Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
by: G. R. Pourmand, et al.
Published: (2012-04-01)

Induction immunosuppression in kidney transplantation: Thymoglobulin® (a literature review)
by: A. V. Pinchuk
Published: (2016-02-01)

Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
by: Tobias Roider, et al.
Published: (2016-12-01)

Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child
by: In Su Choi, et al.
Published: (2015-07-01)

Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review
by: Maarten Naesens, et al.
Published: (2016-09-01)

Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review
by: Maarten Naesens, et al.
Published: (2016-09-01)

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
by: Eolia Brissot, et al.
Published: (2020-07-01)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
by: Ren Lin, et al.
Published: (2019-08-01)

Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007–2016)
by: E. A. Mikhaylova, et al.
Published: (2020-09-01)

Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A
by: Marlene Pereira Garanito, et al.
Published: (2014-09-01)

Implication of thymoglobulin in kidney transplant patients: review article
by: Sudabeh Alatab, et al.
Published: (2015-11-01)

Grafalon® vs. Thymoglobulin® as an induction agent in renal transplantation – A retrospective study
by: Pranaw Kumar Jha, et al.
Published: (2021-01-01)

Study of Aplastic Anaemia with Cyclosporine in Resource Poor Setting
by: Mallikarjuna Shetty, et al.
Published: (2016-06-01)

Single dose thymoglobulin induction therapy in prevention of acute rejection in renal transplant recipients
by: Georgi Abraham, et al.
Published: (2018-01-01)

DYNAMICS OF PROCALCITONIN AT THE PATIENT AFTER COMBINED ORGAN TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2010-06-01)

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
by: Jiang Qiu, et al.
Published: (2019-03-01)

Utility of induction agents in living donor kidney transplantation
by: Radhika Chemmangattu Radhakrishnan, et al.
Published: (2019-01-01)

Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
by: Turun Song, et al.
Published: (2020-04-01)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
by: Ruklanthi de Alwis, et al.
Published: (2020-05-01)

Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
by: Taeyun Kim, et al.
Published: (2020-03-01)

A retrospective comparison of cyclophosphamide plus antithymocyte globulin with cyclophosphamide plus busulfan as the conditioning regimen for severe aplastic anemia
by: L.V.M. Ommati, et al.
Published: (2009-03-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

Anti-thymocyte globulin in haematology: Recent developments
by: Salahuddin Siddiqui, et al.
Published: (2019-01-01)

Cytopenia occurrence in kidney transplant recipients within early post-transplant period
by: Atefeh Jafari, et al.
Published: (2017-01-01)

Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
by: Timothy G. Norwood, et al.
Published: (2020-02-01)

B-cell-rich T-cell lymphoma associated with Epstein-Barr virus-reactivation and T-cell suppression following antithymocyte globulin therapy in a patient with severe aplastic anemia
by: Nobuyoshi Hanaoka, et al.
Published: (2015-09-01)

Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience
by: Vipul Sheth, et al.
Published: (2019-07-01)

The Anti-thymocyte Globulin use makes kidney transplantation journey smooth
by: Akbar Mahmood Sultan, et al.
Published: (2018-06-01)

Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes
by: Yu Wang, et al.
Published: (2017-11-01)

Severe Intraoperative Anaphylaxis Related to Thymoglobulin during Living Donor Kidney Transplantation
by: Muhammad I. Saeed, et al.
Published: (2020-08-01)

TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
by: Silvia F Costa, et al.
Published: (2013-11-01)

Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
by: Florent Malard, et al.
Published: (2018-10-01)

Relationship Between Post-transplant Lymphoproliferative Disorder and Anti-Thymocyte Globulin or Anti-Lymphocyte Globulin
by: Kh. Rahbar, et al.
Published: (2007-02-01)

NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment scheme
by: Ping Zhang, et al.
Published: (2019-12-01)